122 related articles for article (PubMed ID: 4024237)
1. A clinically significant anti-N in a patient whose red cells were negative for N and U antigens.
Ballas SK; Dignam C; Harris M; Marcolina MJ
Transfusion; 1985; 25(4):377-80. PubMed ID: 4024237
[TBL] [Abstract][Full Text] [Related]
2. Anti-M causing delayed hemolytic transfusion reaction.
Alperin JB; Riglin H; Branch DR; Gallagher MT; Petz LD
Transfusion; 1983; 23(4):322-4. PubMed ID: 6879672
[TBL] [Abstract][Full Text] [Related]
3. A clinically significant erythrocyte antibody detectable only by 51Cr survival studies.
Baldwin ML; Barrasso C; Ness PM; Garratty G
Transfusion; 1983; 23(1):40-4. PubMed ID: 6402832
[TBL] [Abstract][Full Text] [Related]
4. Survival of MM red cells during hypothermia in two patients with anti-M.
Kurtz SR; Ouellet R; McMican A; Valeri CR
Transfusion; 1983; 23(1):37-9. PubMed ID: 6829057
[TBL] [Abstract][Full Text] [Related]
5. In vivo survival of K:18 red cells in a recipient with anti-K18.
Barrasso C; Baldwin ML; Drew H; Ness PM
Transfusion; 1983; 23(3):258-9. PubMed ID: 6679384
[TBL] [Abstract][Full Text] [Related]
6. Normal survival of Rh0 (D) negative, LW (a+) red cells in a patient with allo-anti LWa.
Cummings E; Pisciotto P; Roth G
Vox Sang; 1984; 46(5):286-90. PubMed ID: 6428046
[TBL] [Abstract][Full Text] [Related]
7. A hemolytic anti-LKE associated with a rare LKE-negative, "weak P" red blood cell phenotype: alloanti-LKE and alloanti-P recognize galactosylgloboside and monosialogalactosylgloboside (LKE) antigens.
Cooling L; Dake LR; Haverty D; Mullis N; Ellis S; Shayman J; Judd WJ
Transfusion; 2015 Jan; 55(1):115-28. PubMed ID: 25039255
[TBL] [Abstract][Full Text] [Related]
8. Long-term in vivo survival of Rh(D)-negative donor red cells in a patient with anti-LW.
Chaplin H; Hunter VL; Rosche ME; Shirey RS
Transfusion; 1985; 25(1):39-43. PubMed ID: 3918363
[TBL] [Abstract][Full Text] [Related]
9. An example of anti-Yta demonstrating a change in its clinical significance.
AuBuchon JP; Brightman A; Anderson HJ; Kim B
Vox Sang; 1988; 55(3):171-5. PubMed ID: 3238951
[TBL] [Abstract][Full Text] [Related]
10. In vivo studies of the long-term 51Cr red cell survival of serologically incompatible red cell units.
Baldwin ML; Ness PM; Barrasso C; Kickler TS; Drew H; Tsan MF; Shirey RS
Transfusion; 1985; 25(1):34-8. PubMed ID: 3969699
[TBL] [Abstract][Full Text] [Related]
11. Accelerated destruction of radiolabeled red cells due to anti-Coltonb.
Dzik WH; Blank J
Transfusion; 1986; 26(3):246-8. PubMed ID: 3705142
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions.
Aygun B; Padmanabhan S; Paley C; Chandrasekaran V
Transfusion; 2002 Jan; 42(1):37-43. PubMed ID: 11896310
[TBL] [Abstract][Full Text] [Related]
13. Posttransfusion crises in sickle cell anemia: role of delayed hemolytic reactions to transfusion.
Milner PF; Squires JE; Larison PJ; Charles WT; Krauss JS
South Med J; 1985 Dec; 78(12):1462-9. PubMed ID: 4071176
[TBL] [Abstract][Full Text] [Related]
14. A suspected delayed hemolytic transfusion reaction mediated by anti-Joa.
Jajosky RP; Lumm WC; Wise SC; Bollag RJ; Shikle JF
Immunohematology; 2017 Jun; 33(2):73-75. PubMed ID: 28657766
[TBL] [Abstract][Full Text] [Related]
15. Transfusions to group O subjects of 2 units of red cells enzymatically converted from group B to group O.
Lenny LL; Hurst R; Goldstein J; Galbraith RA
Transfusion; 1994 Mar; 34(3):209-14. PubMed ID: 8146892
[TBL] [Abstract][Full Text] [Related]
16. Management of patients with anti-Cartwright (Yta).
Mohandas K; Spivack M; Delehanty CL
Transfusion; 1985; 25(4):381-4. PubMed ID: 4024238
[TBL] [Abstract][Full Text] [Related]
17. A uniform method for the simultaneous blood group phenotyping of Fy
Caesar A; Meyer S; Trost N; Neuenschwander K; Geisen C; Frey BM; Gassner C; Schwind P
Vox Sang; 2018 Feb; 113(2):177-184. PubMed ID: 29044588
[TBL] [Abstract][Full Text] [Related]
18. The occurrence of an auto-immune hemolytic anemia with anti-U specificity in a patient with myelodysplastic syndrome.
Sacher RA; McGinniss MM; Shashaty GG; Jacobson RJ; Rath CE
Am J Clin Pathol; 1982 Mar; 77(3):356-9. PubMed ID: 7072640
[TBL] [Abstract][Full Text] [Related]
19. Accelerated immune red cell destruction in the absence of serologically detectable alloantibodies.
Davey RJ; Gustafson M; Holland PV
Transfusion; 1980; 20(3):348-53. PubMed ID: 6770508
[TBL] [Abstract][Full Text] [Related]
20. Difficulties in identifying antibodies in the Dombrock blood group system in multiply alloimmunized patients.
Strupp A; Cash K; Uehlinger J
Transfusion; 1998; 38(11-12):1022-5. PubMed ID: 9838931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
